# ADVIL DUAL ACTION WITH ACETAMINOPHEN
> **NDA211733** · New Drug Application · Sponsor: HALEON US HOLDINGS · Approved 2020-02-28
## Drug
- **FDA Application Number:** NDA211733
- **Application type:** New Drug Application
- **Brand name:** ADVIL DUAL ACTION WITH ACETAMINOPHEN
- **Generic name:** IBUPROFEN, ACETAMINOPHEN
- **Active ingredients:** ACETAMINOPHEN; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** HALEON US HOLDINGS
- **Manufacturer:** Haleon US Holdings LLC
- **First approval:** 2020-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211733)
---
*AI Analytics · CC0 1.0*